Multidisciplinary Research Center, Shantou University, Shantou 515063, Guangdong, P. R. China.
J Biomater Sci Polym Ed. 2010;21(1):127-40. doi: 10.1163/156856209X410283.
Polyhydroxybutyrate (PHB), co-polyesters of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx), and polylactic acid (PLA) were used to prepare nanoparticles with average sizes of 160, 250 and 150 nm, respectively. A lipid-soluble colorant, rhodamine B isothiocyanate (RBITC), was employed to study drug-release behaviors from these nanoparticles. A high RBITC drug-loading efficiency of over 75% was achieved with all PHA nanoparticles prepared. Macrophage endocytosis led to an intracellular RBITC drug sustained release over a period of at least 20 days for PHB and PHBHHx nanoparticles, while PLA nanoparticles and free drug lasted only 15 days and a week, respectively. Polymer properties and particle sizes showed little effect on drug-release behavior. This study showed for the first time that PHB and PHBHHx can be used effectively to achieve intracellular controlled drug releases.
聚羟基丁酸酯(PHB)、3-羟基丁酸和 3-羟基己酸的共聚酯(PHBHHx)和聚乳酸(PLA)被用于制备平均粒径分别为 160、250 和 150nm 的纳米粒子。脂溶性着色剂,罗丹明 B 异硫氰酸酯(RBITC),被用于研究这些纳米粒子的药物释放行为。所有 PHA 纳米粒子的 RBITC 药物载药效率均超过 75%。巨噬细胞内吞作用导致 PHB 和 PHBHHx 纳米粒子在至少 20 天内持续释放细胞内 RBITC 药物,而 PLA 纳米粒子和游离药物分别仅持续 15 天和 1 周。聚合物性质和粒径对药物释放行为影响不大。这项研究首次表明,PHB 和 PHBHHx 可有效用于实现细胞内的药物控制释放。